Health
Sanofi to start human trials of its second Covid vaccine candidate | – Macau Business
International, MNA | French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second Covid-19 vaccine, with its first still in the…
French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second Covid-19 vaccine, with its first still in the testing phase after having fallen behind in development.
Sanofi and US company Translate Bio are developing the vaccine based on messenger RNA technology.
The phase 1 and 2 trials aim to verify that the vaccine is not dangerous and to provide initial information on its effectiveness.
Phase 3 would be carried out on many more patients to determine its effectiveness.
…
-
General14 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General14 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News23 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General14 hours agoOf saints and sinners | The Spectator Australia